Cargando…
High lymphoid enhancer-binding factor-1 expression is associated with disease progression and poor prognosis in chronic lymphocytic leukemia
We determined lymphoid enhancer-binding factor-1 (LEF1) mRNA expression in 112 chronic lymphocytic leukemia (CLL) samples and assessed correlations with the prognostic markers ZAP70 and CD38, Binet stages, the percentage of lymphocytes in the peripheral blood, and fibromodulin (FMOD) transcripts. Th...
Autores principales: | Erdfelder, Felix, Hertweck, Magdalena, Filipovich, Alexandra, Uhrmacher, Sabrina, Kreuzer, Karl-Anton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222268/ https://www.ncbi.nlm.nih.gov/pubmed/22184516 http://dx.doi.org/10.4081/hr.2010.e3 |
Ejemplares similares
-
Flow Cytometry and Polymerase Chain Reaction-Based Analyses of Minimal Residual Disease in Chronic Lymphocytic Leukemia
por: Uhrmacher, Sabrina, et al.
Publicado: (2010) -
Clonal heterogeneity of lymphoid malignancies correlates with poor prognosis
por: Suguro, Miyuki, et al.
Publicado: (2014) -
Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia
por: Kämpjärvi, Kati, et al.
Publicado: (2014) -
Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies
por: N, Jacquelot, et al.
Publicado: (2021) -
Prognostic Significance of Lymphoid Enhancer-Binding Factor-1 Expression in Egyptian Adult B-Acute Lymphocytic Leukemia Patients
por: Aly, Rabab M., et al.
Publicado: (2015)